Please ensure Javascript is enabled for purposes of website accessibility

Why Disney Stock Jumped Today

By Jeremy Bowman – Updated May 18, 2020 at 6:07PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of the entertainment giant popped as it took a step toward reopening Disney World and investors reacted to positive vaccine news.

What happened

Shares of Walt Disney (DIS -0.51%) were climbing today as the entertainment giant said it was opening a part of Disney World in Florida soon, and as the broader market jumped after Moderna reported a successful phase 1 vaccine trial.

Disney stock was up just over 7% at the close on Monday, while the S&P 500 was up 3.15% on the vaccine news.

The Magic Kingdom at Disney World

The Magic Kingdom at Disney World. Image source: Disney.

So what

In a blog post Saturday, Disney said it would open Disney Springs, a shopping, dining, and entertainment complex at Walt Disney World, on Wednesday as part of a phased reopening of the theme park, with third-party businesses opening their doors. The following week, the company will reopen three stores and venues in Disney Springs owned and operated by the company itself. In accordance with safety protocols, there will be temperature checks upon entry, and guests will be required to wear face coverings. 

The reopening of Disney Springs follows a similar step at Shanghai Disneyland last week, where the park reopened at reduced capacity and tickets sold out.  

Disney shares also got a boost from news that Moderna's vaccine was found to be safe after being tested in 45 people, and was shown to generate antibodies that stopped the virus from spreading. A second phase involving 600 people is set to begin soon, and a third trial testing it on thousands of patients would start in July. Moderna's chief medical officer, Tal Zaks, said that if those trials go well, the vaccine could be ready by the end of the year or early 2021. 

Now what

Progress in discovering a vaccine is obviously good news for Disney. Its businesses are focused on discretionary spending, including theme parks, live sports, and movie and television production. They have been hit hard by the coronavirus, the related shutdowns, and social distancing. A large number of its businesses remain shuttered, so the sooner a vaccine or treatment is discovered, the easier it will be for the company to bring those businesses back to full capacity. 

Similarly, the reopening of Disney Springs is a step in the right direction. Though the company will have to operate its parks at lower capacity and with safety protocols for the foreseeable future, reopening will help stem the cash burn from shuttered theme parks, and build momentum to a wider reopening.




Jeremy Bowman owns shares of Walt Disney. The Motley Fool owns shares of and recommends Walt Disney and recommends the following options: long January 2021 $60 calls on Walt Disney and short July 2020 $115 calls on Walt Disney. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

The Walt Disney Company Stock Quote
The Walt Disney Company
$97.62 (-0.51%) $0.50
Moderna, Inc. Stock Quote
Moderna, Inc.
$123.19 (2.92%) $3.50

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.